Serum anti-mullarian hormone levels in women with unexplained recurrent pregnancy loss.

comparison between serum antimullarian hormone (AMH) in women with history of unexplained recurrent pregnancy loss and multiparous healthy volunteers with comparable age and body mass index ( BMI)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12613001325796

Enrollment

Registered

2013-12-02

Start date

2010-02-13

Completion date

2013-05-01

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

comparison of serum AMH values in two groups; study group comprising 30 women with recurrent unexplained miscarriages between 6 and 12 weeks, and control group of multiparous women of comparable age, and BMI with recent delivery of a full term baby.

Interventions

measurement of serum antimullarian hormone (AMH) by radio immunoassay (RIA) once at time of participant recruitment during early follicular phase of any menstrual cycle in non-pregnant women with history of two or more pregnancy losses before 12 weeks within the last two years.

Eligibility

Sex/Gender

All

Age

20 Years to 35 Years

Healthy volunteers

Inclusion criteria

cases were non-pregnant women with history of 2 or more successive spontaneous pregnancy losses between 6 weeks and 12 weeks gestational age within the last 2 years, while the key inclusion criteria for control group was giving birth of a full term baby within the last 2 years.

Exclusion criteria

presence of a disease or condition that explains the cause of pregnancy loss.

Outcome results